§ Same category · GLP-1 / metabolic peptides
Orforglipron vs Tirzepatide
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Orforglipron
1
vendors tracked
from $23.33/mg
Tirzepatide
10
vendors tracked
from $2.08/mg
◎ Cheapest $/mg:Tirzepatide at $2.08/mg
Orforglipron
Oral small-molecule GLP-1 agonist
No current listings at 0.024mg.
Tirzepatide
Dual GLP-1/GIP agonist
B-
Operational$24.00
$2.40/mg
In stock◎ Best $/mg
Operational
$76.49
$7.65/mg
In stockOn sale▲ 218.7% vs best
B-
Operational$99.00
$9.90/mg
In stock▲ 312.5% vs best
Watch
$99.99
$10.00/mg
Out of stock▲ 316.6% vs best
Operational
$340.19
$34.02/mg
In stock▲ 1317.5% vs best
| Vendor | Grade | Risk | Price | $/mg | Trend | Stock | |
|---|---|---|---|---|---|---|---|
| RetaOneLabs US | B- | Operational | $24.00 ◎ Best $/mg | $2.40 | In stock | Buy with code → | |
| One Day Compounds US | B- | Operational | $76.49 On sale ▲ 218.7% | $7.65 | In stock | Visit → | |
| Atomik Labz US | B- | Operational | $99.00 ▲ 312.5% | $9.90 | In stock | Visit → | |
| Felix Chemical Supply US | B- | Watch | $99.99 ▲ 316.6% | $10.00 | Out | Visit → | |
| Research Peptides Europe EU | A | Operational | $340.19 ▲ 1317.5% | $34.02 | In stock | Visit → |
Sort:
Last crawl 2026-05-09Sort:
2026-05-09About Orforglipron
An oral non-peptide GLP-1 receptor agonist in Phase 3 for obesity and type-2 diabetes. Typically sold as capsules in research-compound form.
About Tirzepatide
A once-weekly dual GIP and GLP-1 receptor agonist studied for type-2 diabetes and obesity. Approved clinically in many jurisdictions; research-compound form is widely distributed.